πŸ‡ΊπŸ‡Έ FDA
Patent

US 9314463

Oligomer-diarylpiperazine conjugates

granted A61KA61K31/495A61K47/60

Quick answer

US patent 9314463 (Oligomer-diarylpiperazine conjugates) held by Nektar Therapeutics expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/495, A61K47/60, A61P, A61P1/04